Literature DB >> 16491413

Serum cystatin C levels in children with sickle cell disease.

Ofelia Alvarez1, Gaston Zilleruelo, Dale Wright, Brenda Montane, Gabriela Lopez-Mitnik.   

Abstract

Patients with sickle cell disease (SCD) may develop kidney dysfunction from childhood. The purpose of this study was to examine the value of serum cystatin C as a marker for glomerular filtration rate (GFR) in children with SCD, as compared to serum creatinine and creatinine clearance (CrCl). Twenty children (ages 9-21, ten males) with SCD with and without albuminuria were studied. The mean serum cystatin for the whole group was 0.89 mg/l (0.5-1.7 mg/l). Mean serum cystatin C was significantly different among the children with proteinuria (n=4), microalbuminuria (n=5), and without albuminuria (n=11) (1.25 mg/l, 0.84 mg/l, and 0.78 mg/l, respectively). The mean GFR derived from serum cystatin was significantly different among these subgroups, becoming abnormal in the proteinuric cohort (63 ml/min per 1.73 m2), in contrast to 94 for the microalbuminuric, and 103 for the normal subgroups. Serum creatinine (mean: 0.58 mg/dl, range: 0.3-1.1) did not change significantly with the level of albuminuria. Mean CrCl remained normal to increased within the subgroups, (133 ml/min per 1.73 m2 for those with proteinuria, 144 for those with microalbuminuria, and 163 for the normal subgroup). We conclude that serum cystatin C correlates with the level of albuminuria and may be a reliable method to measure renal function in SCD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16491413     DOI: 10.1007/s00467-006-0033-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  39 in total

1.  Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients.

Authors:  L Risch; R Herklotz; A Blumberg; A R Huber
Journal:  Clin Chem       Date:  2001-11       Impact factor: 8.327

2.  Serum creatinine and fat-free mass (lean body mass).

Authors:  R Swaminathan; P Major; H Snieder; T Spector
Journal:  Clin Chem       Date:  2000-10       Impact factor: 8.327

3.  Cystatin C--a new marker of glomerular filtration rate in children independent of age and height.

Authors:  A Bökenkamp; M Domanetzki; R Zinck; G Schumann; D Byrd; J Brodehl
Journal:  Pediatrics       Date:  1998-05       Impact factor: 7.124

4.  Impaired creatinine secretion after an intravenous creatinine load is an early characteristic of the nephropathy of sickle cell anaemia.

Authors:  José Herrera; Estela Avila; Crispín Marín; Bernardo Rodríguez-Iturbe
Journal:  Nephrol Dial Transplant       Date:  2002-04       Impact factor: 5.992

5.  Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients.

Authors:  Michele Mussap; Michele Dalla Vestra; Paola Fioretto; Alois Saller; Mariacristina Varagnolo; Romano Nosadini; Mario Plebani
Journal:  Kidney Int       Date:  2002-04       Impact factor: 10.612

6.  Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate.

Authors:  J Kyhse-Andersen; C Schmidt; G Nordin; B Andersson; P Nilsson-Ehle; V Lindström; A Grubb
Journal:  Clin Chem       Date:  1994-10       Impact factor: 8.327

7.  Renal handling of radiolabelled human cystatin C in the rat.

Authors:  O Tenstad; A B Roald; A Grubb; K Aukland
Journal:  Scand J Clin Lab Invest       Date:  1996-08       Impact factor: 1.713

8.  Early blood transfusions protect against microalbuminuria in children with sickle cell disease.

Authors:  Ofelia Alvarez; Brenda Montane; Gabriela Lopez; James Wilkinson; Tracie Miller
Journal:  Pediatr Blood Cancer       Date:  2006-07       Impact factor: 3.167

9.  Serum cystatin C may predict the prognostic stages of patients with IgA nephropathy prior to renal biopsy.

Authors:  Y Tomino; S Suzuki; T Gohda; M Kobayashi; S Horikoshi; H Imai; T Saito; T Kawamura; N Yorioka; T Harada; Y Yasumoto; H Kida; Y Kobayashi; M Endoh; H Sato; K Saito
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

10.  Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality.

Authors:  D R Powars; D D Elliott-Mills; L Chan; J Niland; A L Hiti; L M Opas; C Johnson
Journal:  Ann Intern Med       Date:  1991-10-15       Impact factor: 25.391

View more
  17 in total

1.  Biomarkers for early detection of sickle nephropathy.

Authors:  Nambirajan Sundaram; Michael Bennett; Jamie Wilhelm; Mi-Ok Kim; George Atweh; Prasad Devarajan; Punam Malik
Journal:  Am J Hematol       Date:  2011-05-31       Impact factor: 10.047

2.  Correlation between cystatin C- and renal scan-determined glomerular filtration rate in children with spina bifida.

Authors:  Catherine Morgan; Ambikaipakan Senthilselvan; Fiona Bamforth; Michael Hoskinson; Manjula Gowrishankar
Journal:  Pediatr Nephrol       Date:  2007-10-09       Impact factor: 3.714

3.  Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial.

Authors:  Russell E Ware; Renee C Rees; Sharada A Sarnaik; Rathi V Iyer; Ofelia A Alvarez; James F Casella; Barry L Shulkin; Eglal Shalaby-Rana; C Frederic Strife; John H Miller; Peter A Lane; Winfred C Wang; Scott T Miller
Journal:  J Pediatr       Date:  2010-01       Impact factor: 4.406

Review 4.  Sickle cell nephropathy: challenging the conventional wisdom.

Authors:  Amy M Becker
Journal:  Pediatr Nephrol       Date:  2011-01-04       Impact factor: 3.714

5.  Effect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia.

Authors:  Ofelia Alvarez; Scott T Miller; Winfred C Wang; Zhaoyu Luo; M Beth McCarville; George J Schwartz; Bruce Thompson; Thomas Howard; Rathi V Iyer; Sohail R Rana; Zora R Rogers; Sharada A Sarnaik; Courtney D Thornburg; Russell E Ware
Journal:  Pediatr Blood Cancer       Date:  2012-01-31       Impact factor: 3.167

6.  Glomerular hyperfiltration and albuminuria in children with sickle cell anemia.

Authors:  Banu Aygun; Nicole A Mortier; Matthew P Smeltzer; Jane S Hankins; Russell E Ware
Journal:  Pediatr Nephrol       Date:  2011-05-11       Impact factor: 3.714

Review 7.  The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait.

Authors:  Rakhi P Naik; Vimal K Derebail
Journal:  Expert Rev Hematol       Date:  2017-10-30       Impact factor: 2.929

8.  Losartan for the nephropathy of sickle cell anemia: A phase-2, multicenter trial.

Authors:  Charles T Quinn; Santosh L Saraf; Victor R Gordeuk; Courtney D Fitzhugh; Susan E Creary; Prasad Bodas; Alex George; Ashok B Raj; Alecia C Nero; Catherine E Terrell; Lisa McCord; Adam Lane; Hans C Ackerman; Yu Yang; Omar Niss; Michael D Taylor; Prasad Devarajan; Punam Malik
Journal:  Am J Hematol       Date:  2017-07-19       Impact factor: 10.047

Review 9.  Sickle cell disease and the kidney.

Authors:  Jon I Scheinman
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-02

Review 10.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.